Orphic Therapeutics identifies and acquires underperforming biopharmaceutical therapies that are currently indicated for chronic orphan diseases. These specific drugs, though proven effective, are presently underutilized or no longer distributed. Orphic's business model works to repurpose these therapies and make them available to benefit the small patient populations which rely on their long-term therapeutic efficacy. With a patient-driven mission of, "Advancing proven therapies until there is a cure," Orphic Therapeutics fulfills the specialized requirements of serving patients, providers and the orphan drug community. To learn more, visit orphictherapeutics.com
| Website | http://orphictherapeutics.com |
| Revenue | $200000 |
| Employees | 2 (0 on RocketReach) |
| Founded | 2014 |
| Address | 17295 Chesterfield Airport Road Suite 200, Chesterfield, Missouri 63005, US |
| Phone | +1 636-733-7510 |
| Industry | Pharmaceutical Manufacturing, Drug Manufacturing & Research, Pharmaceuticals, Healthcare |
| Keywords | Orphan Diseases, Drug Development, Pharmaceutical Acquisitions, Drug Repositioning, Biotech Acquisitions, Pharmaceutical Investment, Drug Commercialization, Drug Licensing, New Drug Applications |
| Competitors | Novartis, Amgen, Regeneron, Gilead Sciences, Vertex Pharmaceuticals, Biogen, Moderna Therapeutics, CRISPR Therapeutics, Editas Medicine, Sarepta Therapeutics, Inc. +42 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 2834 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies |
Looking for a particular Orphic Therapeutics employee's phone or email?
Orphic Therapeutics Questions
The Orphic Therapeutics annual revenue was $200000 in 2026.
Orphic Therapeutics is based in Chesterfield, Missouri.
The NAICS codes for Orphic Therapeutics are [325, 32, 3254, 32541].
The SIC codes for Orphic Therapeutics are [283, 2834, 28].
Related Companies
